Diabetes Mellitus Clinical Trials in Miami, Florida

22 recruitingMiami, Florida

Showing 120 of 22 trials

Recruiting
Phase 3

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1152 locationsNCT07064473
Recruiting
Phase 1Phase 2

A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM

Type 2 Diabetes Mellitus (T2DM)Obese or Overweight Healthy Volunteers
Alnylam Pharmaceuticals144 enrolled20 locationsNCT06845202
Recruiting
Not Applicable

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

Diabetes Mellitus, Type 2
Cleerly, Inc.7,500 enrolled123 locationsNCT06112418
Recruiting
Phase 2

FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)

Type 1 Diabetes Mellitus
Sanofi192 enrolled80 locationsNCT06111586
Recruiting
Phase 1

A Study of GNTI-122 in Adults Recently Diagnosed With T1D

Type 1 Diabetes MellitusType 1 Diabetes (T1D)
GentiBio, Inc16 enrolled10 locationsNCT06919354
Recruiting
Phase 3

A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes

Diabetes Mellitus, Type 1
Novo Nordisk A/S877 enrolled193 locationsNCT07076199
Recruiting
Not Applicable

Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

Type 1 Diabetes Mellitus
Rodolfo Alejandro18 enrolled1 locationNCT01999361
Recruiting
Phase 3

Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Chronic Kidney DiseasesType 2 Diabetes Mellitus
Prokidney685 enrolled95 locationsNCT05099770
Recruiting

Long Term Surveillance of Islet Transplant Recipients Following Complete Graft Loss

Type 1 Diabetes Mellitus
Rodolfo Alejandro60 enrolled1 locationNCT02000687
Recruiting

Long Term Follow up of Recipients of Functional Islet Allografts

Type 1 Diabetes Mellitus
Rodolfo Alejandro30 enrolled1 locationNCT01999374
Recruiting
Phase 2

Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus

Type II Diabetes Mellitus
Sun Pharmaceutical Industries Limited285 enrolled21 locationsNCT07282743
Recruiting
Phase 3

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

Diabetes Mellitus, Type 1Impaired Hypoglycemic AwarenessSevere Hypoglycemia
Vertex Pharmaceuticals Incorporated52 enrolled29 locationsNCT04786262
Recruiting
Phase 1

Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency

Type II Diabetes Mellitus
Sun Pharmaceutical Industries Limited40 enrolled3 locationsNCT07385547
Recruiting
Phase 1Phase 2

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

Type 1 DiabetesType 1 Diabetes MellitusType 1 Diabetes Mellitis+7 more
COUR Pharmaceutical Development Company, Inc.72 enrolled31 locationsNCT06783309
Recruiting
Phase 1Phase 2

Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes

Diabetes Mellitus, Type 1Type 1 Diabetes
Creative Medical Technology Holdings Inc18 enrolled1 locationNCT05626712
Recruiting
Phase 1

Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)

Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC64 enrolled11 locationsNCT07089784
Recruiting
Phase 1

A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)

Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC52 enrolled4 locationsNCT07242469
Recruiting
Phase 2

A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus

T2DM (Type 2 Diabetes Mellitus)
Ascletis Pharma (China) Co., Limited100 enrolled8 locationsNCT07321678
Recruiting
Not Applicable

Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes

Diabetes Mellitus, Type 2DiabetesType 2 Diabetes+2 more
Endogenex, Inc.264 enrolled45 locationsNCT06267391
Recruiting

Type 1 Diabetes Recurrence in Pancreas Transplants

Diabetes Mellitus, Type 1
University of Miami400 enrolled1 locationNCT01047865